| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 37.73% | 1.89% | 6.07% | 95/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 35.57% | -15.82% | -7.5% | 100/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 38.45% | 2% | 0.98% | 94/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 38.08% | -16.44% | 2.85% | 96/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 37.03% | 2% | -12.37% | 98/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 42.25% | 6.72% | -7.29% | 90/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-06-30 | 45.58% | 4.3% | 15.11% | 85/140 | 53.95% | 佰仁医疗 | 88.34% | 行业排名> |
| 2023-12-31 | 39.59% | 0.8% | -9.4% | 100/140 | 53.57% | 佰仁医疗 | 88.56% | 行业排名> |
| 2023-06-30 | 43.7% | 2% | 11.25% | 90/140 | 53.81% | 佰仁医疗 | 89.27% | 行业排名> |
| 2022-12-31 | 39.28% | 2% | 2% | 100/140 | 54.01% | 佰仁医疗 | 89.28% | 行业排名> |

微信公众号
证券之星APP


